Free Trial

OpGen (OPGN) Competitors

OpGen logo
$4.60 +0.55 (+13.58%)
As of 09:57 AM Eastern

OPGN vs. DCGO, XGN, EUDA, SERA, QIPT, NAKA, KDLY, ATPC, CORBF, and PIII

Should you be buying OpGen stock or one of its competitors? The main competitors of OpGen include DocGo (DCGO), Exagen (XGN), EUDA Health (EUDA), Sera Prognostics (SERA), Quipt Home Medical (QIPT), KindlyMD (NAKA), Kindly MD (KDLY), Agape ATP (ATPC), Global Cord Blood (CORBF), and P3 Health Partners (PIII). These companies are all part of the "healthcare" industry.

OpGen vs. Its Competitors

DocGo (NASDAQ:DCGO) and OpGen (NASDAQ:OPGN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.

DocGo presently has a consensus price target of $3.56, indicating a potential upside of 150.70%. Given DocGo's stronger consensus rating and higher probable upside, research analysts clearly believe DocGo is more favorable than OpGen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DocGo
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
OpGen
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

DocGo has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500. Comparatively, OpGen has a beta of -1.66, indicating that its stock price is 266% less volatile than the S&P 500.

56.4% of DocGo shares are owned by institutional investors. Comparatively, 2.7% of OpGen shares are owned by institutional investors. 2.7% of DocGo shares are owned by company insiders. Comparatively, 43.8% of OpGen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

DocGo has a net margin of -0.12% compared to OpGen's net margin of -1,140.36%. DocGo's return on equity of 2.52% beat OpGen's return on equity.

Company Net Margins Return on Equity Return on Assets
DocGo-0.12% 2.52% 1.70%
OpGen -1,140.36%N/A -287.58%

In the previous week, DocGo had 1 more articles in the media than OpGen. MarketBeat recorded 1 mentions for DocGo and 0 mentions for OpGen. DocGo's average media sentiment score of 1.89 beat OpGen's score of 0.00 indicating that DocGo is being referred to more favorably in the media.

Company Overall Sentiment
DocGo Very Positive
OpGen Neutral

DocGo has higher revenue and earnings than OpGen.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DocGo$616.55M0.23$19.99M-$0.02-71.00
OpGen$2.67M17.33-$32.67MN/AN/A

Summary

DocGo beats OpGen on 12 of the 14 factors compared between the two stocks.

Get OpGen News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPGN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPGN vs. The Competition

MetricOpGenMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$46.31M$23.77M$5.57B$9.31B
Dividend YieldN/AN/A4.23%4.03%
P/E RatioN/AN/A28.6119.73
Price / Sales17.339.58411.31174.27
Price / CashN/AN/A36.0257.96
Price / Book-0.400.118.235.67
Net Income-$32.67M-$27.68M$3.23B$257.79M
7 Day PerformanceN/AN/A-0.01%0.52%
1 Month Performance-6.12%-3.06%5.60%8.84%
1 Year Performance49.30%24.65%26.54%14.18%

OpGen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPGN
OpGen
N/A$4.60
+13.6%
N/A+32.4%$46.31M$2.67M0.00100Gap Down
DCGO
DocGo
2.1823 of 5 stars
$1.52
-3.8%
$3.56
+134.2%
-55.3%$161.13M$520.50M-76.004,407Positive News
XGN
Exagen
3.3316 of 5 stars
$6.96
-1.3%
$7.50
+7.8%
+242.4%$150.16M$55.64M-8.29220News Coverage
Positive News
EUDA
EUDA Health
1.2549 of 5 stars
$3.33
-1.5%
N/A-15.4%$125.59M$4.01M0.002Positive News
SERA
Sera Prognostics
0.3976 of 5 stars
$2.42
-2.8%
N/A-61.6%$93.81M$80K-2.57120Gap Down
QIPT
Quipt Home Medical
2.9558 of 5 stars
$1.73
-2.8%
$2.85
+64.7%
-35.3%$77.33M$245.91M-8.241,200
NAKA
KindlyMD
N/A$12.04
-5.6%
N/AN/A$76.88M$2.47M-15.64N/AGap Up
KDLY
Kindly MD
N/A$12.75
-2.8%
N/A+414.5%$76.78M$2.47M-16.56N/A
ATPC
Agape ATP
0.5442 of 5 stars
$1.40
+2.6%
N/A-65.6%$68.01M$1.29M-2.3240
CORBF
Global Cord Blood
N/A$0.55
-62.1%
N/AN/A$66.85M$196.12M0.001,200
PIII
P3 Health Partners
3.232 of 5 stars
$6.40
+0.3%
$16.25
+153.9%
-77.1%$45.86M$1.49B-0.14500Positive News

Related Companies and Tools


This page (NASDAQ:OPGN) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners